Global Anti-inflammatory Therapeutics Market 2017-2021: Emergence of Novel Anti-Inflammatory Drugs with AbbVie, Amgen, Johnson & Johnson & Pfizer Dominating - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Anti-inflammatory Therapeutics Market 2017-2021" report to their offering.

Thee global anti-inflammatory therapeutics market to grow at a CAGR of 6.10% during the period 2017-2021.

Global Anti-Inflammatory therapeutics market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion operating in this market. To calculate the market size, the report considers sales of branded, off-label, and generic drugs.

One trend in the market is emergence of novel anti-inflammatory drugs. Cytokines are proteins produced by immune cells. These protein molecules facilitate communication between cells and play a pivotal role in cell development and differentiation including regulation of immune response.

According to the report, one driver in the market is availability of targeted therapy. The global anti-inflammatory therapeutics market is no stranger to biologics. The biologics are macromolecules, consisting of genetically engineered protein derived from living cells. As biologics can be produced by using DNA recombinant technology, they offer targeted therapy and can also be modified depending on patient's need. Owing to their benefits over other small molecules, biologics are dominating the global anti-inflammatory therapeutics market with more than 60% of market share in 2016.

Key vendors:

  • AbbVie
  • Amgen
  • Johnson & Johnson
  • Pfizer

Other prominent vendors:

  • Boehringer Ingelheim
  • Eli Lilly
  • Novartis

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Inflammation: An overview

Part 06: Market landscape

Part 07: Key clinical trial

Part 08: Market segmentation by application

Part 09: Market segmentation by drug class

Part 10: Geographical segmentation

Part 11: Decision framework

Part 12: Drivers and challenges

Part 13: Market trends

Part 14: Vendor landscape

Part 15: Key vendor analysis

Part 16: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/x8fsfb/global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs